Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.71 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.71 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 16/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.71 |
| ▸ | CCR2 | P41597 | 1/20 | 0.71 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.71 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL674945 | 0.97 | CXCR4 (0.75) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Bromide SCHEMBL1259133 | 0.95 | CXCR4 (0.66) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Bromide SCHEMBL7495511 | 0.94 | CXCR4 (0.68) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL675084 | 0.92 | CXCR4 (0.67) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL17929341 | 0.92 | CXCR4 (0.72) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL1259323 | 0.92 | CXCR4 (0.67) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL674847 | 0.90 | CXCR4 (0.65) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| Bromide SCHEMBL1259195 | 0.90 | SIGMAR1 (0.69) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL29823861 | 0.89 | CXCR4 (0.69) | CXCR4MEN1CHRM2CHRM1ADRA2C | |
| SCHEMBL21961925 | 0.88 | SIGMAR1 (0.71) | CXCR4MEN1CHRM2CHRM1ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133291-B1 | CYCLIC POLYAMINES FOR TREATING THROMBOCYTOPENIA | SMITHKLINE BEECHAM CORP (US) | 2006-01-11 | — | — | EP | disclosed |
| US-6498155-B1 | SUCH AS 1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS(1,4,8,11-TETRAAZACYCLOTETRADECANE); THROMBOPOIETIN RECEPTOR AGONISTS | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |
| EP-1133291-A4 | METHODS OF TREATING THROMBOCYTOPENIA | SMITHKLINE BEECHAM CORP (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1133291-A1 | METHODS OF TREATING THROMBOCYTOPENIA | SMITHKLINE BEECHAM CORPORATION (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000028987-A1 | METHODS OF TREATING THROMBOCYTOPENIA | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-25 | — | — | WO | disclosed |